HBV vaccine(VLP Biotech)

N/A

Report date: 2025/03/18 14:44:55

Base Information

Drug NameHBV vaccine(VLP Biotech)
Drug Alias NameN/A
ClassificationVaccines > Application > Therapeutic vaccine
Mechanisms of ActionImmunostimulantsLarge envelope protein Pre-S1 inhibitors
TargetsLarge envelope protein Pre-S1
Therapy Area/IndicationsHepatitis DHepatitis B, Chronic
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesVLP Biotech Inc
China Registration ClassN/A

Develop Information

Active CompaniesVLP Biotech Inc
Inactive CompaniesN/A
Active IndicationsHepatitis DHepatitis B, Chronic
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A